Dr. Ontiveros is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
210 W McKinley Ave
Ste 1
Decatur, IL 62526Phone+1 217-879-6600Fax+1 217-876-6606
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Alabama Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2007 - Present
IL State Medical License 2017 - 2026
NY State Medical License 2013 - 2017
IA State Medical License 2012 - 2014
AL State Medical License 2005 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsCladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hyp...Amanda Przespolewski, Monica Reddy Muppidi, Craig W. Freyer, Wenyan Ji, Tara Cronin
Leukemia & Lymphoma. 2021-02-16 - 20 citationsIntensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience.Pankit Vachhani, Raed Al Yacoub, Austin Miller, Fan Zhang, Tara Cronin
Leukemia Research. 2018-12-01 - 16 citationsRemission of Severe, Relapsed, and Refractory TTP after Multiple Cycles of BortezomibManu R. Pandey, Pankit Vachhani, Evelena P. Ontiveros
Case Reports in Hematology. 2017-03-06
Journal Articles
- Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperiencePankit Vachhani, Evelena P Ontiveros, Leukemia Research
- Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperiencePankit Vachhani, Evelena P Ontiveros, Leukemia Research
Authored Content
- Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperienceOctober 2018
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
